Details for Patent: 7,850,990
Which drugs does patent 7,850,990 protect, and when does it expire?
Patent 7,850,990 protects VYXEOS and is included in one NDA.
Protection for VYXEOS has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-three patent family members in thirteen countries.
Summary for Patent: 7,850,990
| Title: | Compositions for delivery of drug combinations |
| Abstract: | Compositions which comprise delivery vehicles having stably associated therewith non-antagonistic combinations of two or more agents, such as antineoplastic agents, are useful in achieving non-antagonistic effects when combinations of drugs are administered. |
| Inventor(s): | Paul Tardi, Troy Harasym, Murray Webb, Clifford Shew, Marcel Bally, Lawrence Mayer, Andrew Janoff |
| Assignee: | BCCA BRANCH , Jazz Pharmaceuticals Therapeutics Inc |
| Application Number: | US10/417,631 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 7,850,990
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharms Therap | VYXEOS | cytarabine; daunorubicin | POWDER;INTRAVENOUS | 209401-001 | Aug 3, 2017 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,850,990
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 345775 | ⤷ Start Trial | |||
| Austria | 475411 | ⤷ Start Trial | |||
| Australia | 2002331480 | ⤷ Start Trial | |||
| Australia | 2002331481 | ⤷ Start Trial | |||
| Australia | 2002351626 | ⤷ Start Trial | |||
| Australia | 2004231977 | ⤷ Start Trial | |||
| Canada | 2365806 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
